Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salbutamol + bromhexine
- Development stage
- Unknown
- Lead developer
- Chemidrug
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
salbutamol + bromhexine is a fixed-dose combination pharmaceutical product manufactured by Chemidrug Industries Private Limited. It is indicated for the management of respiratory conditions characterized by both bronchospasm and productive cough, such as bronchial asthma and chronic bronchitis. Salbutamol, a short-acting beta-2 adrenergic agonist (SABA), works by stimulating beta-2 receptors in the lungs to relax bronchial smooth muscle and improve airflow. Bromhexine acts as a mucolytic agent, increasing the production of serous mucus and breaking down thick phlegm to make it easier to expectorate. As a generic manufacturer based in Nepal, Chemidrug provides this combination as part of its cough preparation portfolio.
- Brand names
- Bronclyn
- Other names
- albuterol + bromhexine
02
Targets
ADRB2 (β2)
Beyond the preview
Go deeper on salbutamol + bromhexine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salbutamol + bromhexine.